Longeveron Executives Speak at Global CardioVascular Clinical Trialists Forum
I'm PortAI, I can summarize articles.
Longeveron Inc.'s Chief Science Officer, Dr. Joshua Hare, and Chief Medical Officer, Dr. Nataliya Agafonova, will speak at the Global CardioVascular Clinical Trialists Forum in Washington, D.C., from December 8-10, 2025. They will discuss cell therapy heart failure trials, delivery routes for cell therapies, and strategies for innovation in cell therapy clinical trials.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments